The drug atlas
Toxicology & Immunosuppression/Calcineurin inhibitors & antiproliferativeslow yield

Transplant immunosuppressants

also: ciclosporin · tacrolimus · mycophenolate · calcineurin inhibitor

Overview

The transplant/autoimmune immunosuppressants not covered elsewhere — calcineurin inhibitors and mycophenolate. (Azathioprine→GI, methotrexate→MSK, corticosteroids→Endo, biologics→Derm/MSK.)

Mechanism

Ciclosporin and tacrolimus inhibit calcineurin → block NFAT → ↓IL-2 → ↓T-cell activation. Mycophenolate inhibits inosine monophosphate dehydrogenase → blocks purine (guanosine) synthesis in lymphocytes.

Indications

  • Solid-organ transplant (rejection prophylaxis)
  • Severe autoimmune disease (e.g. lupus nephritis)

The agents

Tacrolimuscalcineurin inhibitor

narrow index, levels

Nephrotoxic; diabetogenic; neurotoxicity, tremor; CYP3A4.

Ciclosporincalcineurin inhibitor

levels

Nephrotoxic; GUM HYPERTROPHY, hypertrichosis, hypertension; CYP3A4.

Mycophenolate mofetilantiproliferative

Myelosuppression, GI; teratogenic.

Adverse effects

Nephrotoxicity (calcineurin inhibitors)serious

Dose by levels.

Infection / malignancy (immunosuppression)serious
Ciclosporin: gum hypertrophy + hypertrichosis; tacrolimus: diabetescommon
Mycophenolate: teratogenic, marrow suppressionserious

Cautions & contraindications

Live vaccinesall
Mycophenolate in pregnancypregnancy
CYP3A4 interactions (calcineurin inhibitors)all

Levels swing — grapefruit, azoles, macrolides, rifampicin.

Interactions

  • CYP3A4 (ciclosporin/tacrolimus); nephrotoxin stacking

Monitoring & kinetics

Drug levels (CNIs), renal function, BP, glucose, FBC

Oral; narrow therapeutic index — therapeutic drug monitoring.

Source: BNF — Immunosuppressants